Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000914475-24-000222
Filing Date
2024-12-03
Accepted
2024-12-03 18:52:58
Documents
1
Period of Report
2024-11-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1733269971.html 4  
1 FORM 4 wk-form4_1733269971.xml 4 8050
  Complete submission text file 0000914475-24-000222.txt   9512
Mailing Address 12780 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 6027 EDGEWOOD BEND COURT SAN DIEGO CA 92130 (858) 617-7600
NEUROCRINE BIOSCIENCES INC (Issuer) CIK: 0000914475 (see all company filings)

EIN.: 330525145 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O NEUROCRINE BIOSCIENCES, INC. 12780 EL CAMINO REAL SAN DIEGO CA 92130
Business Address
Onyia Jude (Reporting) CIK: 0001894425 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22705 | Film No.: 241524212